ARDX Ardelyx Inc

Ardelyx Inc is a clinical stage biopharmaceutical company. It engages in the discovery, development and commercialization of non-systemic, molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal and metabolic diseases.

$1.82  +0.03 (1.68%)
As of 12/08/2022 15:58:54 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/19/2014
Outstanding shares:  187,459,645
Average volume:  24,228,572
Market cap:   $343,051,150
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BN89V40
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy